Compugen (CGEN) Operating Leases (2019 - 2026)
Compugen's (CGEN) quarterly Operating Leases came in at $2.4 million in Q1 2026, up 1.06% year-on-year from $2.3 million in Q1 2025, and down 2.71% quarter-over-quarter from $2.4 million in Q4 2025.
Compugen (CGEN) Operating Leases (2019 - 2026) Analysis & Trends
Compugen has disclosed Operating Leases across 8 years of filings, most recently posting $2.4 million for Q1 2026.
- Operating Leases for Q1 2026 came in at $2.4 million, up 1.06% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.4 million (up 1.06% YoY), and the FY2025 annual result was $2.4 million, down 1.01% from the prior year.
- Operating Leases came in at $2.4 million for Q1 2026 at Compugen, down from $2.4 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $2.7 million in Q1 2024 to a low of $719000.0 in Q4 2023.
- The 5-year median for Operating Leases is $2.3 million (2025), against an average of $1.9 million.
- Across the five-year window, Operating Leases slumped 45.2% in 2023 and jumped 242.7% in 2024, its largest moves.
- Compugen's Operating Leases stood at $1.3 million in 2022, then tumbled by 45.2% to $719000.0 in 2023, then surged by 242.7% to $2.5 million in 2024, then dropped by 1.01% to $2.4 million in 2025, then fell by 2.71% to $2.4 million in 2026.
- The last three Operating Leases figures came in at $2.4 million (Q1 2026), $2.4 million (Q4 2025), and $2.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Compugen | 189.59 Mn | 97.83 Mn | 352,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.37 Mn |
| Dec 31, 2025 | 2.44 Mn |
| Sep 30, 2025 | 2.46 Mn |
| Jun 30, 2025 | 2.50 Mn |
| Mar 31, 2025 | 2.35 Mn |
| Dec 31, 2024 | 2.46 Mn |
| Sep 30, 2024 | 2.50 Mn |
| Jun 30, 2024 | 2.58 Mn |
| Mar 31, 2024 | 2.68 Mn |
| Dec 31, 2023 | 719,000.00 |
| Sep 30, 2023 | 818,000.00 |
| Jun 30, 2023 | 991,000.00 |
| Mar 31, 2023 | 1.17 Mn |
| Dec 31, 2022 | 1.31 Mn |
| Sep 30, 2022 | 1.38 Mn |
| Jun 30, 2022 | 1.49 Mn |
| Mar 31, 2022 | 1.77 Mn |
| Dec 31, 2021 | 1.98 Mn |
| Sep 30, 2021 | 2.04 Mn |
| Jun 30, 2021 | 2.14 Mn |